CS Paper Radar

COMBIO: Automated Discovery of a Compact Composite Biomarker from Routine Laboratory Panels

Tomer D. Meirman, Lior S. Rokach, Bracha Shapira, Seffi Cohen, Noa Dagan

cs.LG ·submitted 2026-11-06 07:33 UTC · v1

Abstract

Machine-learning models based on routine laboratory panels can predict outcomes but can be difficult to interpret and operationalize. We present COMBIO, an automated pipeline that distils such a model into a compact closed-form biomarker. The composite is a product of laboratory measurements raised to integer powers from minus two to two. The sign of each exponent indicates whether higher values of the corresponding measurement increase or decrease the composite. Shapley additive explanation values from the gradient-boosted reference model rank five candidate measurements and guide eligible exponent signs. An exhaustive search over small integer exponents selects the formula on an inner validation set, before evaluation on the reserved test set. We evaluated COMBIO across six tasks: three National Health and Nutrition Examination Survey outcomes, liver-disease classification in the Indian Liver Patient Dataset, and Medical Information Mart for Intensive Care IV in-hospital mortality and sepsis case-finding, with external evaluation in the eICU Collaborative Research Database for the two hospital tasks. Across the six test sets, COMBIO's area under the receiver operating characteristic curve differed by at most 0.03 from logistic regression using the five candidate laboratory measurements. The hospital mortality composite had an area under the curve of 0.698 in the external database. A version restricted to widely available measurements in the source hospital database achieved an area under the curve of 0.786 in a cohort covering 92% of admissions. The multiplicative representation provides compactness rather than additional accuracy, and local validation and recalibration are required before clinical use.

Comment
27 pages including supplementary material; 4 figures

Closest papers

Nearest neighbours by meaning across the whole index.

A Physiology-Informed Digital Twin Framework for Simulating Liver Health Progression

cs.LG ·2026-08-15 ·Sumaiya Afroz Mila, Sandip Ray
similarity 0.57
Abstract · This paper is under review at IEEE Journal of Biomedical and Health Informatics (JBHI)

We present a physiology-informed digital twin of the human liver designed for longitudinal simulation of liver function and early-stage disease progression. The model, referred to as HEPATWIN, integrates key hepatic processes, including carbohydrate, lipid, and protein metabolism, bilirubin conjugation, bile production, and detoxification, within a unified systems-level framework to generate clinically observable biomarker trajectories. Unlike purely data-driven approaches, HEPATWIN incorporates mechanistic representations of liver physiology and patient-specific inputs such as diet, activity, and baseline biomarkers to simulate disease evolution over time. To ensure consistency with clinical progression patterns, we introduce a stage-transition-driven calibration mechanism that aligns simulated outputs with population-level biomarker distributions across disease stages, including NAFLD, fibrosis, and cirrhosis. Validation using the NIDDK NAFLD dataset demonstrates that HEPATWIN produces longitudinal biomarker estimates within clinically acceptable ranges and can forecast trajectories over multi-year horizons. Furthermore, simulated biomarkers retain sufficient clinical signal to support downstream NASH detection with competitive performance relative to models using ground-truth laboratory data. These results highlight the potential of physiology-informed digital twins for personalized, non-invasive diagnosis and prediction of organ health in general and liver health monitoring in particular.

0.06

Predicting Future Organ Dysfunction in ICU Patients Using Temporal Convolutional Networks on MIMIC-IV Data

cs.AI ·2026-08-29 ·Razan Albouq, Asra Aslam
similarity 0.57
Abstract

Predicting future organ dysfunction in Intensive Care Unit (ICU) patients is critical for early clinical intervention, yet existing machine learning approaches have largely treated the Sequential Organ Failure Assessment (SOFA) score as an input to binary mortality prediction rather than as a continuous clinical outcome in its own right. We investigate the extent to which a Temporal Convolutional Net work (TCN) can predict next-day SOFA scores from multivariate ICU time-series data extracted from MIMIC-IV, characterise the relative contribution of each organ system to total SOFA variance and deterioration, and identify distinct trajectory patterns across ICU stays. A residual TCN trained on three-day sliding windows achieved a five-fold cross-validation R2 of 0.740 +- 0.013 and MAE of 1.431 +- 0.022, outperforming a naive persistence baseline on RMSE and R2. SHAP interpretability analysis revealed that the model functions primarily as a severity-anchoring mechanism rather than a true sequence model, with predictions dominated almost entirely by the most recent observation day. Cardiovascular dysfunction emerged as the strongest discriminator of both cross-sectional severity and acute deterioration, and unsupervised trajectory clustering identified two clinically meaningful phenotypes, an improving group (58.9%) and a persistently severe group (41.1%), differentiated by cardiovascular, hepatic, coagulation, and renal involvement. We conclude that TCNs can extract meaningful predictive signal from ICU physiological data, but that short input windows and complete-case selection bias currently limit their clinical utility, motivating future work on longer input horizons, alternative missing-data strategies, and external validation.

0.11

Potential of Artificial Intelligence Algorithms for Identification of Relevant Diagnostic and Prognostic Biomarkers of Early-Stage Liver Cancer

cs.AI ·2026-09-14 ·Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba +2 more
hot direction similarity 0.57
Abstract · 25 pages, 11 figures, 4 tables, under review

This study explores the use of deep learning and explainable artificial intelligence to diagnose hepatocellular carcinoma (HCC) and define effective biomarkers across five different stages of disease development using a transcriptomic biomarker HCC dataset constructed via semi-supervised learning from three source datasets. Several deep learning experiments were conducted with different feature extraction techniques and gene sets to identify the most effective features for training high-accuracy models with minimal loss. The best-performing model, using 15 selected genes with the SelectKBest algorithm, achieved 90.74% accuracy, while the model with the lowest recorded loss of 0.3187 was obtained using 20 selected genes. To address the issue of class imbalance in the dataset, a weighted training approach was conducted, and for model transparency and interpretability a SHAP-based XAI analysis provided insights into the model's decision-making, consistently finding DNAJB14 as the most influential gene. Functional validation in this study has provided compelling evidence that DNAJB14 plays an important role in the adverse properties of HCC and that its inhibition effectively reverses tumour cell migration, invasion, colony and sphere formation. The main limitation of this study is the dataset's class imbalance, and while weighted training helped mitigate this, further research and additional data are needed to guarantee model generalizability. Future studies should also explore the influence of genetic variations, environmental factors, and clinical differences on model performance across diverse populations.

0.34

CoMedBench: A Multi-Source Benchmark of Synthetic Medical Data Fidelity and Downstream Utility

cs.LG ·2026-08-13 ·Akanta Das, Farhad Al-Amin Dipto, Mrinmoy Sarkar Anto, David Rehkopf, Ayin Vala +1 more
benchmark similarity 0.56
Abstract

Access to clinical data is essential for developing reliable healthcare machine learning systems, but direct use of electronic health records is constrained by privacy regulation, institutional review, data-use agreements, and the risk of re-identification. Synthetic data promises a practical alternative: it can preserve useful statistical and clinical structure while reducing exposure of sensitive patient records. Prior studies often evaluate a single generator, one dataset, or a narrow downstream task, making it difficult to know when synthetic data can support model development and when it fails to preserve task-critical signal. We introduce CoMedBench, a reproducible benchmark that evaluates a family of generators under a common clinical-validity framework and one shared training and evaluation engine, spanning static tabular and temporal downstream tasks on established critical-care datasets. In total the benchmark spans 37 dataset-task pairs across two modalities consists of 20 static tabular and 17 temporal ICU time-series-drawn from seven public data sources: three intensive-care databases (MIMIC-III, MIMIC-IV, and eICU) together with the UCI Machine Learning Repository, the CDC BRFSS diabetes cohort (2015), NHANES (1999-2014), and the pycox survival datasets (GBSG and METABRIC). The benchmark evaluates both statistical fidelity and task utility by comparing models trained and tested across real and synthetic data. In these settings, synthetic training data preserves most of the downstream signal: on tabular tasks the reference generator CoMed-CTGAN retains a mean AUROC utility (the synthetic-to-real performance ratio) of 90.6%, rising to 97.3% for the strongest generator, CoMed-TVAE. Temporal ICU tasks are harder and more generator-sensitive: CoMed-CTGAN retains 81.6% (AUROC) and only 64.0% under the imbalance-sensitive AUPRC, whereas CoMed-TVAE still retains ~95% (AUROC).

0.04

CHARTER: Auditing Reference Substitution in Hierarchical Compact-Evidence Evaluation for Computational Pathology

cs.CV cs.LG ·2026-10-06 ·Hyun Do Jung, Jungwon Choi, Soojung Choi, Yujin Oh, Hwiyoung Kim
similarity 0.56
Abstract

In digital pathology, compact evidence is often used to explain or audit predictions made by whole-slide image multiple instance learning models. In hierarchical compact-evidence pipelines, candidate filtering introduces a strategy-specific candidate-conditioned prediction alongside the original full-bag prediction. If the evaluation reference changes while the intended target remains the original full-bag prediction, however, not only can the measured fidelity of the same compact evidence change, but comparisons between competing candidate strategies can also change. To make this dependence explicit, we introduce CHARTER, a reference-aware evaluation charter that asks researchers to DECLARE the intended target and reference, QUANTIFY candidate-induced prediction shift, and AUDIT the stability of comparative conclusions. Across the 15 comparisons in our main five-seed Random-K audit, 4 showed determinate reversals; in a matched native-ranking stress test, the ACMIL comparison changed from REVERSED to PRESERVED. CHARTER turns otherwise implicit candidate-filtering and reference choices into an auditable evaluation specification, helping distinguish genuine preservation of the intended prediction from apparent gains induced by changing the prediction being explained.

0.17

Clinically Interpretable Biological Age Estimation Using CatBoost and SHAP with Continuous and Categorical Features from NHANES

cs.LG stat.CO ·2026-10-14 ·Yanni Sun, Zheng Qu, Kevin Ren, Zhanglin Lin Cui
published similarity 0.56
Abstract · 31 pages, 6 figures, accepted by 2026 ICSA Applied Statistics Symposium, June 14 - June 17, 2026 at Arlington, Virginia, USA

Biological age (BA) captures inter-individual variation in physiological aging beyond chronological age (CA). Although machine-learning models have advanced BA estimation, many rely primarily on continuous laboratory biomarkers, and SHapley Additive exPlanations (SHAP) dependence plots are typically interpreted visually. We developed a clinically interpretable machine-learning framework for BA estimation using heterogeneous clinical data from the National Health and Nutrition Examination Survey (NHANES 2011-March 2020, N = 24,983 adults aged >= 18). A CatBoost regression model incorporated 44 demographic, laboratory, physical examination, and lifestyle predictors to estimate CA, defining model-estimated age as BA. SHAP provided multi-level interpretability. Crucially, building on standard visual inspection, we implemented a prespecified automated procedure directly on SHAP dependence plots to quantify feature-value ranges associated with lowest and highest BA contributions, corresponding adjustment magnitudes, and zero-crossing thresholds. Model-estimated BA strongly correlated with CA in held-out testing data (Pearson r = 0.798, P < 0.001). Population-level SHAP identified blood urea nitrogen, serum glucose, vigorous recreational activity, red cell distribution width, and alanine aminotransferase among the leading predictors, with three categorical variables ranking among the top 25. Automated quantitative SHAP analysis mapped predictor-specific ranges, effect sizes, and inflection points, while waterfall plots enabled individual explanations. By extending qualitative visual interpretation to reproducible quantitative metrics across heterogeneous clinical data, this framework enhances transparency and provides a scalable methodological foundation for biological aging research and precision health.

0.38

Improving Medical Calculation of LLMs with Embedded Coding

cs.AI cs.CL ·2026-09-25 ·Tianshi Ming, Yingying Zhang, Xian Wu
benchmark similarity 0.56
Abstract

Large Language Models (LLMs) perform well on medical examinations and question-answering benchmarks, but remain unreliable on medical calculation tasks that require exact numerical outputs. These calculations support high-stakes decisions such as medication dosing, organ-function assessment, and prognostic scoring, for which even small errors can have serious clinical consequences. We introduce MedCode, a framework that improves medical calculation by training LLMs to generate embedded executable code. Given a clinical context, the model identifies the relevant calculator, extracts its input variables, and produces a script that delegates arithmetic operations to a deterministic interpreter. Executing the script returns the calculated value together with an explanation and the appropriate unit. We construct supervised fine-tuning (SFT) and preference datasets from the MedCalc benchmark and additionally curate a dataset for calculation tasks in Intensive Care Unit (ICU) scenarios. We further propose weighted Direct Preference Optimization (wDPO), which adaptively emphasizes preference pairs that are difficult for the model to distinguish. Experiments with LLaMA3-8B, Qwen2.5-7B, and Mistral-7B show absolute accuracy gains of 20--30 percentage points, demonstrating the effectiveness of embedded code generation for medical calculation.

0.24

Optimizing for the decision not the prediction: an exploration of Smooth Net Benefit as a training objective

cs.LG ·2026-09-11 ·Koen M. F. Gorgels, Lasai Barreñada, Maarten van Smeden, Ben Van Calster, Ewout W. Steyerberg +1 more
benchmark similarity 0.55
Abstract · 22 pages, 5 figures, 2 tables. Code and supplementary data available

Objective Prediction models are commonly trained using objectives such as Bernoulli negative log-likelihood (NLL), although downstream clinical decisions may depend on specific risk thresholds. We introduce Smooth Net Benefit ($σ$NB), a differentiable approximation of Net Benefit designed to align model training with threshold-specific clinical utility. Materials and Methods We evaluated $σ$NB as a training objective for logistic regression, generalized additive models (GAMs), and XGBoost with three Hessian implementations. Experiments used the Framingham cardiovascular risk dataset and 44 TabZilla datasets comprising 72 dataset-threshold combinations. Results $σ$NB training did not consistently improve Net Benefit in Framingham. Across the TabZilla benchmark, mean standardized Net Benefit for logistic regression increased from 0.5669 with NLL to 0.5765 with $σ$NB (mean difference 0.0096, 95% CI -0.0001 to 0.0193). For GAMs, mean standardized Net Benefit decreased from 0.5921 to 0.5625 (mean difference -0.0296, 95% CI -0.0721 to 0.0129). For XGBoost, NLL achieved 0.6745 compared with 0.6723--0.6735 across $σ$NB implementations. In logistic regression, $σ$NB gains were positively associated with the performance advantage of XGBoost over NLL-trained logistic regression. Discussion The effect of $σ$NB was context dependent, with modest gains concentrated in logistic regression and little benefit for more flexible model classes. This suggests that decision-focused optimization may be most useful when limited model flexibility leaves greater scope for improvement. Conclusion Our results do not support $σ$NB as a general replacement for NLL training, but support further investigation of decision-focused objectives in settings where conventional likelihood-based training may not adequately capture decision-relevant structure.

0.37